---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-005042"
form_type: "8-K"
ticker: "NERV"
cik: "0001598646"
company_name: "Minerva Neurosciences, Inc."
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T03:22:10.960013+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Nasdaq Panel grants Minerva continued listing subject to equity compliance by March 31, 2025

## Summary
- Company must file disclosure on transactions to meet $2.5M minimum stockholders' equity by 3/31/25.
- Must also provide 12-month income projections with underlying assumptions to Panel by same deadline.
- Company is working toward compliance but states no assurance of regaining or maintaining listing.
- Original deficiency was market value below $35M; now equity compliance is the key condition.

## SEC filing metadata
- accession: 0001193125-25-005042
- form_type: 8-K
- ticker: NERV
- cik: 0001598646
- company_name: Minerva Neurosciences, Inc.
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1598646/000119312525005042/0001193125-25-005042-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1598646/000119312525005042/d906093d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-005042
- JSON: https://secwatch.observer/filing/0001193125-25-005042.json
- Plain text: https://secwatch.observer/filing/0001193125-25-005042.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.